InvestorsHub Logo
Followers 604
Posts 24107
Boards Moderated 3
Alias Born 12/06/2009

Re: None

Tuesday, 10/24/2017 1:59:16 AM

Tuesday, October 24, 2017 1:59:16 AM

Post# of 27644
MYMETICS INTELLECTUAL PROPERTY

WO/1999/025377 (GP41 mutee) Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection Mymetics Corp. Expiration date: November 16, 2018

WO/2005/010033 (GP41 ter) New soluble and stabilized trimeric form of GP 41 polypeptide Mymetics Corp. Expiration date: July 28, 2024

WO/2007/099446 (Virosome-P1) Virosome-like vesicles comprising gp41 - derived antigens Mymetics Corp. + INSERM + Pevion Expiration date: January 3, 2027

US/61/202 215 (GP41 4th gen) Mymetics Corp. Expiration date: February 5, 2029

US/61/202 219 (Splitting GP41) Mymetics Corp. Expiration date: February 5, 2029

WO/2004/106366 (UK39) Methods for synthetizing conformationally constrained peptides, peptidomimetics and use of such peptidomimetics as synthetic vaccines Mymetics Corp. Expiration date: June 1, 2024

WO/2004/078099 (AMA49) Compositions and methods for the generation of immune response against Malaria Mymetics Corp. Expiration date: March 2, 2023

WO/2004/045641 (APRECS) Antigen-complexes Bestewil BV Expiration date: November 19, 2023

WO/2004/110486 (Lipopeptide) Functionally reconstituted viral membranes containing adjuvant Bestewil BV Expiration date: June 17, 2024


WO/2004071492 (DCPC) Virosome-like particles Bestewil BV Expiration date: December 2, 2023
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News